244 related articles for article (PubMed ID: 32404475)
21. Systematic analysis of the expression and prognosis relevance of FBXO family reveals the significance of FBXO1 in human breast cancer.
Liu Y; Pan B; Qu W; Cao Y; Li J; Zhao H
Cancer Cell Int; 2021 Feb; 21(1):130. PubMed ID: 33622332
[TBL] [Abstract][Full Text] [Related]
22. Long noncoding RNA LINC00473 indicates a poor prognosis of breast cancer and accelerates tumor carcinogenesis by competing endogenous sponging miR-497.
Bai J; Zhao WY; Li WJ; Ying ZW; Jiang DQ
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3410-3420. PubMed ID: 31081095
[TBL] [Abstract][Full Text] [Related]
23. Increased expression of miR-330-3p: a novel independent indicator of poor prognosis in human breast cancer.
Wang H; Chen SH; Kong P; Zhang LY; Zhang LL; Zhang NQ; Gu H
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(6):1726-1730. PubMed ID: 29630118
[TBL] [Abstract][Full Text] [Related]
24. Clinical relevance of the deregulated kallikrein-related peptidase 8 mRNA expression in breast cancer: a novel independent indicator of disease-free survival.
Michaelidou K; Ardavanis A; Scorilas A
Breast Cancer Res Treat; 2015 Jul; 152(2):323-36. PubMed ID: 26099606
[TBL] [Abstract][Full Text] [Related]
25. The BMP inhibitor DAND5 in serum predicts poor survival in breast cancer.
Chi Y; Yao L; Hu X; Huang S; Huang N; Li S; Shao Z; Wu J
Oncotarget; 2016 Mar; 7(12):14951-62. PubMed ID: 26908452
[TBL] [Abstract][Full Text] [Related]
26. NUF2 as an anticancer therapeutic target and prognostic factor in breast cancer.
Lv S; Xu W; Zhang Y; Zhang J; Dong X
Int J Oncol; 2020 Dec; 57(6):1358-1367. PubMed ID: 33173994
[TBL] [Abstract][Full Text] [Related]
27. Differential expression of pyruvate dehydrogenase E1A and its inactive phosphorylated form among breast cancer subtypes.
Zaher DM; Talaat IM; Hussein A; Hachim MY; Omar HA
Life Sci; 2021 Nov; 284():119885. PubMed ID: 34384830
[TBL] [Abstract][Full Text] [Related]
28. MiR-200b expression in breast cancer: a prognostic marker and act on cell proliferation and apoptosis by targeting Sp1.
Yao Y; Hu J; Shen Z; Yao R; Liu S; Li Y; Cong H; Wang X; Qiu W; Yue L
J Cell Mol Med; 2015 Apr; 19(4):760-9. PubMed ID: 25639535
[TBL] [Abstract][Full Text] [Related]
29. High Eg5 expression predicts poor prognosis in breast cancer.
Jin Q; Huang F; Wang X; Zhu H; Xian Y; Li J; Zhang S; Ni Q
Oncotarget; 2017 Sep; 8(37):62208-62216. PubMed ID: 28977938
[TBL] [Abstract][Full Text] [Related]
30. LRRC59 serves as a novel biomarker for predicting the progression and prognosis of bladder cancer.
Zhang P; Xie X; Li C; Zhang C; Liang P
Cancer Med; 2023 Oct; 12(19):19758-19776. PubMed ID: 37706625
[TBL] [Abstract][Full Text] [Related]
31. Prognostic significance of interferon regulating factor 4 (IRF4) in node-negative breast cancer.
Heimes AS; Madjar K; Edlund K; Battista MJ; Almstedt K; Gebhard S; Foersch S; Rahnenführer J; Brenner W; Hasenburg A; Hengstler JG; Schmidt M
J Cancer Res Clin Oncol; 2017 Jul; 143(7):1123-1131. PubMed ID: 28251349
[TBL] [Abstract][Full Text] [Related]
32. Long non-coding RNA LINC01287 promotes breast cancer cells proliferation and metastasis by activating Wnt/ß-catenin signaling.
Song C; Sun P; He Q; Liu LL; Cui J; Sun LM
Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4234-4242. PubMed ID: 31173295
[TBL] [Abstract][Full Text] [Related]
33. High expression of VARS promotes the growth of multiple myeloma cells by causing imbalance in valine metabolism.
Shi R; DU W; He Y; Hu J; Yu H; Zhou W; Guo J; Feng X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Jun; 48(6):795-808. PubMed ID: 37587064
[TBL] [Abstract][Full Text] [Related]
34. HPD overexpression predicts poor prognosis in breast cancer.
Wang X; Shang Y; Yang L; Tan X; Zhang H; Shan C; Liu S
Pathol Res Pract; 2019 Sep; 215(9):152524. PubMed ID: 31277952
[TBL] [Abstract][Full Text] [Related]
35. Rab22a is a novel prognostic marker for cell progression in breast cancer.
He M; Shen L; Jiang C; Gao G; Wang K; Jiao Y; Sun L; Cui Y; Ke Z; Yang Z
Int J Mol Med; 2020 Apr; 45(4):1037-1046. PubMed ID: 32124943
[TBL] [Abstract][Full Text] [Related]
36. Prognostic and biological significance of microRNA-127 expression in human breast cancer.
Wang S; Li H; Wang J; Wang D; Yao A; Li Q
Dis Markers; 2014; 2014():401986. PubMed ID: 25477702
[TBL] [Abstract][Full Text] [Related]
37. Expression and clinical prognostic value of CYB561 in breast cancer.
Zhou X; Shen G; Ren D; Guo X; Han J; Guo Q; Zhao F; Wang M; Dong Q; Li Z; Zhao J
J Cancer Res Clin Oncol; 2022 Aug; 148(8):1879-1892. PubMed ID: 35486183
[TBL] [Abstract][Full Text] [Related]
38. [Low expression of lncRNA-GAS5 promotes epithelial-mesenchymal transition of breast cancer cells in vitro].
Ding YX; Duan KC; Chen SL
Nan Fang Yi Ke Da Xue Xue Bao; 2017 Nov; 37(11):1427-1435. PubMed ID: 29180320
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-588 is downregulated and may have prognostic and functional roles in human breast cancer.
Yu M; Zhang X; Li H; Zhang P; Dong W
Med Sci Monit; 2017 Nov; 23():5690-5696. PubMed ID: 29187727
[TBL] [Abstract][Full Text] [Related]
40. Investigating the role of FADS family members in breast cancer based on bioinformatic analysis and experimental validation.
Zhao T; Gao P; Li Y; Tian H; Ma D; Sun N; Chen C; Zhang Y; Qi X
Front Immunol; 2023; 14():1074242. PubMed ID: 37122728
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
